Could Deepinder Goyal's ‘Temple’ Revolutionize Brain Monitoring?
Synopsis
Key Takeaways
New Delhi, Dec 7 (NationPress) Deepinder Goyal, the visionary founder and CEO of Zomato's parent company Eternal, unveiled a sneak peek of his latest innovation, a device that monitors brain blood flow named ‘Temple’. On his Instagram account, he shared a brief teaser accompanied by the caption “Getting there,” offering followers a first look at this compact wearable gadget.
The intrigue surrounding the device grew when Goyal was spotted with a tiny golden sensor positioned on the right side of his forehead. Many curious users began inquiring about its function, leading him to clarify its purpose in a previous LinkedIn update.
Goyal revealed that Temple acts as an ‘experimental device’ aimed at accurately measuring brain blood flow in real-time and continuously. He noted its creation stemmed from his exploration of the recently discussed Gravity Ageing Hypothesis.
In a series of posts last month, he elaborated on this “scientific yet unconventional” theory, positing that gravity may have a direct impact on human aging.
He emphasized that he presents this theory not solely as a CEO, but as an inquisitive individual willing to delve into unconventional scientific inquiries. He highlighted that while Newton defined gravity and Einstein explained its distorting effect on spacetime, he suspects gravity may also contribute to a shorter human lifespan.
Goyal is investigating the relationship between three critical factors: how maintaining an upright posture marginally decreases blood flow to the brain, the sensitivity of specific brain areas like the hypothalamus and brainstem to minor circulation changes, and how these areas influence the aging process.
According to him, understanding these connections could illuminate new aspects of the aging process.
He disclosed that he has been utilizing the Temple device for a year and is optimistic about its potential as a significant global health instrument. Importantly, he pointed out that brain blood flow is already recognized as a crucial biomarker for aging, longevity, and cognitive health.
Therefore, he believes that Temple retains its relevance even if his gravity-based aging theory turns out to be inaccurate.
In response to speculation that the hypothesis serves merely as a promotional tactic for the device, Goyal firmly rejected such claims. He asserted that Temple would be a “small, cute company” compared to Eternal and emphasized that he would never jeopardize consumer trust for marketing purposes.
He reiterated that the Gravity Ageing Hypothesis emerged from authentic scientific curiosity, not as a vehicle for selling the device.